Investigation of the Ringer Perfusion Balloon Catheter
Completed · Not applicable
Conditions studied: Coronary Artery Perforation
In brief
The objective of this study is to demonstrate reasonable assurance that the Ringer catheter can be safely used to manage hemorrhage due to coronary vessel perforations while facilitating distal perfusion under the conditions of use prescribed in the labeling.
Key facts
- Study ID
- NCT04849169
- Run by
- Vascular Solutions LLC
- People needed
- 30
- Starts
- 2022-07-18
- Expected to finish
- 2023-11-21
- Last updated by the study team
- 2023-12-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- At least 18 years of age at the time of the PCI procedure
- Subject has fluoroscopically confirmed vessel perforation (classified as any type) requiring management of hemorrhage until a definitive treatment is determined
- Female subjects of childbearing potential must have a negative pregnancy test per standard of care for PCI
You may not qualify if…
- The perforation location prevents complete inflation or proper placement of the Ringer catheter, as detailed in the Instructions for Use (IFU).
Where it is running
- Piedmont Heart Institute — Atlanta, Georgia, United States
- Emory Heart & Vascular Center — Atlanta, Georgia, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Brigham & Women's Hospital — Boston, Massachusetts, United States
- Henry Ford Health System — Detroit, Michigan, United States
- University of Washington Medical Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.